National Health Investors (NHI) Fundamentals 2026 — P/E 25.8x, Revenue Analysis | SniperIQ
National Health Investors (NHI) is a US-listed Real Estate company in REIT - Healthcare Facilities with a market capitalization of
National Health Investors (NHI) has a market capitalization of approximately
National Health Investors's trailing twelve-month P/E ratio is 25.8x, with a price-to-book (P/B) of 2.6x. Valuation multiples are best compared with Real Estate sector peers rather than read in isolation.
National Health Investors runs a net profit margin of 36.8%, a gross margin of 61.3%, and an operating margin of 48.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
National Health Investors reported revenue of
National Health Investors offers a trailing dividend yield of about 4.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
National Health Investors carries a debt-to-equity ratio of 0.84x and a current ratio of 0.83x, with a market beta of 0.54. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For National Health Investors (NHI) the key facts are: market cap
Get National Health Investors's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.